ArticleEndoscopy international open2025
US multicenter outcomes of endoscopic ultrasound-guided gallbladder drainage with lumen-apposing metal stents for acute cholecystitis.
Article in Endoscopy international open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07655778 (Multicenter Comparative Clinical Trial), which is not on this map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Multicenter Comparative Clinical Trial: EUS-Guided Gallbladder Drainage Versus Conservative Management in Patients Unfit for Surgery After a Biliary Event Without Cholecystitis. DRECON Study: (DRainage, Endoscopic Ultrasound, CONservative)
Who cites it
11 citing papers in PubMed.
- Clinical Challenges in Acute Cholecystitis: Endoscopic Drainage Strategies (EUS-GBD vs. ET-GBD) in Patients with Surgical Contraindications.Journal of clinical medicine · 2026Review
- Toward Tailored EUS-Guided Gallbladder Drainage in the Era of Lumen-Apposing Metal Stent.Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2026Article
- Endoscopic Ultrasound-Guided Gallbladder Drainage for Acute Cholecystitis in Billroth II Anatomy via Afferent Limb.ACG case reports journal · 2026Article
- Endoscopic ultrasound-guided gallbladder drainage for acute cholecystitis: Should the endoscopic option become the status quo?World journal of gastrointestinal pharmacology and therapeutics · 2026Review
- [Interventional endoscopic ultrasound in the hepatopancreatobiliary system : What is possible, what is safe and what is meaningful?]Innere Medizin (Heidelberg, Germany) · 2026Review
- Lumen-apposing metal stent in a right renal cyst as a complication of endoscopic ultrasound-guided gallbladder drainage.Endoscopy · 2025Article
- Natural orifice surgery for rescue of stent misplacement in endoscopic gallbladder drainage.VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2025Article
- The Effect of Lumen-Apposing Metal Stent (LAMS) in Acute Cholecystitis Unfit for Surgery: Good Tidings.Diagnostics (Basel, Switzerland) · 2025Review
- Interventional endosonography comes of age: an update on endoscopic ultrasonography-guided drainage and anastomosis procedures.Singapore medical journal · 2025Review
- Review
- Endoscopic ultrasound gallbladder drainage (EUS-GBD) with LAMS: While we know how to drain we are still questioning who to drain.Endoscopy international open · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
55 authors.
Funding
Abstract
Background and study aims: EUS-guided gallbladder drainage (EUS-GBD) using lumen apposing metal stents (LAMS) has excellent technical and short-term clinical success for acute cholecystitis (AC). The goals of this study were to determine the long-term clinical outcomes and adverse events (AEs) of EUS-GBD with LAMS. Patients and methods: A multicenter, retrospective study was conducted at 18 US tertiary care institutions. Inclusion criteria: any AC patient with attempted EUS-GBD with LAMS and minimum 30-day post-procedure follow-up. Long-term clinical success was defined as absence of recurrent acute cholecystitis (RAC) > 30 days and long-term AE was defined as occurring > 30 days from the index procedure. Results: A total of 109 patients were included. Technical success was achieved in 108 of 109 (99.1%) and initial clinical success in 106 of 109 (97.2%). Long-term clinical success was achieved in 98 of 109 (89.9%) over a median follow-up of 140 days (range 30-1188). On multivariable analysis (MVA), acalculous cholecystitis (odds ratio [OR] 15.93, 95% confidence interval [CI] 1.22-208.52, Conclusions: EUS-GBD with LAMS has a high rate of long-term clinical success and modest AE rates in patients with AC and is a reasonable destination therapy for high-risk surgical candidates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.